Download FREE Report Sample
Download Free samplePneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
Pneumococcal Vaccine Market contains market size and forecasts of Pneumococcal Vaccine in global, including the following market information:
Global Pneumococcal Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pneumococcal Vaccine Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Pneumococcal Vaccine companies in 2021 (%)
The global Pneumococcal Vaccine market was valued at 7408.6 million in 2021 and is projected to reach US$ 7972.1 million by 2028, at a CAGR of 1.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PPSV 23 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pneumococcal Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumococcal Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Pneumococcal Vaccine Market Segment Percentages, by Type, 2021 (%)
PPSV 23
PCV 7/13
PCV 10
Global Pneumococcal Vaccine Market, by End User, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Pneumococcal Vaccine Market Segment Percentages, by End User, 2021 (%)
Child
Adult
Global Pneumococcal Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Pneumococcal Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumococcal Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pneumococcal Vaccine revenues share in global market, 2021 (%)
Key companies Pneumococcal Vaccine sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Pneumococcal Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
